List of serched triples

A total of 22252 records found

#18892 middle Confidence
Subject: AgNORs (Molecular markers)
are_applied_in
Object: stomach_cancer_diagnosis (diagnosis)
Original: Argyrophilic nucleolar organizer regions (AgNORs)#are applied in#diagnosis of stomach/ lung/ liver/ colon/ and breast cancers
🏥 Diagnostic aids 📄 PMID: 15601569
#18891 middle Confidence
Subject: AgNORs (Molecular markers)
helps_distinguish
Object: malignant_breast_tumors (Malignant tumors)
Original: Ag-NORs#help distinguish#benign and malignant tumors of the breast
🏥 Diagnostic aids 📄 PMID: 8731895
#18890 middle Confidence
Subject: AgNORs (Molecular markers)
helps_distinguish
Object: benign_breast_tumors (Benign tumors)
Original: Ag-NORs#help distinguish#benign and malignant tumors of the breast
🏥 Diagnostic aids 📄 PMID: 8731895
#18889 middle Confidence
Subject: CD44 (Cell adhesion molecules)
is_linked_to
Object: cancer_progression (Tumor progression)
Original: DEC1/ CK1/ PCNA/ and CD44#are linked to#cancer progression
🏥 Prognostic significance 🧬 DEC1/CSNK1/PCNA/CD44 📄 PMID: 35266015
#18888 middle Confidence
Subject: PCNA (Proliferation-related proteins)
is_linked_to
Object: cancer_progression (Tumor progression)
Original: DEC1/ CK1/ PCNA/ and CD44#are linked to#cancer progression
🏥 Prognostic significance 🧬 DEC1/CSNK1/PCNA/CD44 📄 PMID: 35266015
#18887 middle Confidence
Subject: CSNK1 (Protein kinase)
is_linked_to
Object: cancer_progression (Tumor progression)
Original: DEC1/ CK1/ PCNA/ and CD44#are linked to#cancer progression
🏥 Prognostic significance 🧬 DEC1/CSNK1/PCNA/CD44 📄 PMID: 35266015
#18886 middle Confidence
Subject: 1-Dec (Transcription Factors)
is_linked_to
Object: cancer_progression (Tumor progression)
Original: DEC1/ CK1/ PCNA/ and CD44#are linked to#cancer progression
🏥 Prognostic significance 🧬 DEC1/CSNK1/PCNA/CD44 📄 PMID: 35266015
#18885 middle Confidence
Subject: PCNA (Proliferation-related proteins)
reveals
Object: decreased_proliferative_activity (Cell proliferation activity)
Original: PCNA#revealed#decreased proliferative activity in treated prostatic carcinoma
🏥 Response to treatment 🧬 PCNA 📄 PMID: 8977987
#18884 middle Confidence
Subject: NADT (Treatment options)
decreases
Object: serum_PSA (Serum markers)
Original: NADT#decreased#prostate volume/ tumor volume/ and serum PSA
🏥 Response to treatment 🧬 KLK3 📄 PMID: 8977987
#18883 middle Confidence
Subject: NADT (Treatment options)
decreases
Object: tumor_volume (Tumor volume)
Original: NADT#decreased#prostate volume/ tumor volume/ and serum PSA
🏥 Response to treatment 🧬 KLK3 📄 PMID: 8977987
#18882 middle Confidence
Subject: NADT (Treatment options)
decreases
Object: prostate_volume (Organ volume)
Original: NADT#decreased#prostate volume/ tumor volume/ and serum PSA
🏥 Response to treatment 🧬 KLK3 📄 PMID: 8977987
#18881 middle Confidence
Subject: NADT (Treatment options)
was_evaluated_by
Object: cellular_proliferation_indices (Cell proliferation markers)
Original: Effectiveness of NADT#was evaluated by#prostate volume/ tumor volume/ serum PSA/ staging/ and cellular proliferation indices
🏥 Response to treatment 🧬 KLK3 📄 PMID: 8977987
#18880 middle Confidence
Subject: NADT (Treatment options)
was_evaluated_by
Object: staging (Disease Stage)
Original: Effectiveness of NADT#was evaluated by#prostate volume/ tumor volume/ serum PSA/ staging/ and cellular proliferation indices
🏥 Response to treatment 🧬 KLK3 📄 PMID: 8977987
#18879 middle Confidence
Subject: NADT (Treatment options)
was_evaluated_by
Object: serum_PSA (Serum markers)
Original: Effectiveness of NADT#was evaluated by#prostate volume/ tumor volume/ serum PSA/ staging/ and cellular proliferation indices
🏥 Response to treatment 🧬 KLK3 📄 PMID: 8977987
#18878 middle Confidence
Subject: NADT (Treatment options)
was_evaluated_by
Object: tumor_volume (Tumor volume)
Original: Effectiveness of NADT#was evaluated by#prostate volume/ tumor volume/ serum PSA/ staging/ and cellular proliferation indices
🏥 Response to treatment 🧬 KLK3 📄 PMID: 8977987
#18877 middle Confidence
Subject: NADT (Treatment options)
was_evaluated_by
Object: prostate_volume (Organ volume)
Original: Effectiveness of NADT#was evaluated by#prostate volume/ tumor volume/ serum PSA/ staging/ and cellular proliferation indices
🏥 Response to treatment 🧬 KLK3 📄 PMID: 8977987
#18876 middle Confidence
Subject: AgNORs (The cell nucleus has silver-stained nucleoli)
offer
Object: prognostic_indicator (Prognostic indicators)
Original: AgNORs#offer#an additional prognostic indicator in testicular tumors
🏥 Prognostic significance 📄 PMID: 10677996
#18875 middle Confidence
Subject: nucleolar_organizer_regions (Nucleolar organizing region)
proposed_as
Object: prognostic_variable (Prognostic variables)
Original: Nucleolar organizer regions#proposed as#new prognostic variable in breast carcinomas
🏥 Prognosis 📄 PMID: 1695228
#18874 middle Confidence
Subject: AgNOR_number (Number of nucleolar organizer region markers)
differs_significantly_between
Object: PCNA_negative_nuclei (Protein negative nuclei)
Original: AgNOR numbers/ perimeters/ and contour indices#differ significantly between#PCNA-positive and -negative nuclei in PA samples
🏥 diagnosis 🧬 PCNA 📄 PMID: 15287541
#18873 middle Confidence
Subject: AgNOR_number (Number of nucleolar organizer region markers)
differs_significantly_between
Object: PCNA_positive_nuclei (Protein positive nuclei)
Original: AgNOR numbers/ perimeters/ and contour indices#differ significantly between#PCNA-positive and -negative nuclei in PA samples
🏥 diagnosis 🧬 PCNA 📄 PMID: 15287541